Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

Global Giants Like Pfizer In Better Position To Tackle Counterfeiting

This article was originally published in PharmAsia News

Executive Summary

HONG KONG - Drug companies are stepping up efforts to fight counterfeit products that are emerging around the world as potential profits grow and penalties, compared to those associated with dealing in illegal narcotics, are relatively low

You may also be interested in...



IFPMA Outlines Plan For Fighting Counterfeit Drugs

HONG KONG - The threat of counterfeit anti-infective drugs is rising rapidly, even as pharmaceutical companies, regulators and industry associations develop new strategies to deal with the problem

PharmAsia News Business Bulletin

A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).

Table

View full table

Tags:
Latest Headlines

Boehringer Ingelheim Overtakes Bayer As Germany’s Biggest Pharma Company

Synthekine Joins Quest To Tame IL-2 In Cancer Therapies

Novartis Draws Out Its APPLAUSE

China VBP, Localization And Other Strategies - How Far And Which Way?

See All
UsernamePublicRestriction

Register

SC074215

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By